# Role of Dexmedetomidine as Synergistic Agent

> **NCT06662175** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Lady Reading Hospital, Pakistan** · enrollment: 166 (estimated)

## Conditions studied

- Dexmedetomidine
- Hyperbaric Bupivacaine
- Subarachnoid Anesthesia

## Interventions

- **DRUG:** Hyperbaric bupivacaine
- **DRUG:** hyperbaric bupivacaine and dexmedetomidine

## Key facts

- **NCT ID:** NCT06662175
- **Lead sponsor:** Lady Reading Hospital, Pakistan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11
- **Primary completion:** 2025-07
- **Final completion:** 2025-09
- **Target enrollment:** 166 (ESTIMATED)
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06662175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06662175, "Role of Dexmedetomidine as Synergistic Agent". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06662175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*